Detalhe da pesquisa
1.
Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses.
J Virol
; 96(1): e0134321, 2022 01 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34668778
2.
Evolution of broadly cross-reactive HIV-1-neutralizing activity: therapy-associated decline, positive association with detectable viremia, and partial restoration of B-cell subpopulations.
J Virol
; 87(22): 12227-36, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-24006439
3.
Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure.
Sci Rep
; 10(1): 1902, 2020 02 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32024974
4.
Guiding the humoral response against HIV-1 toward a MPER adjacent region by immunization with a VLP-formulated antibody-selected envelope variant.
PLoS One
; 13(12): e0208345, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30566493
5.
HIV-1 Dual Infected LTNP-EC Patients Developed an Unexpected Antibody Cross-Neutralizing Activity.
PLoS One
; 10(8): e0134054, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26258485